How do I lower my risk of inflammatory bowel disease?

Benefits hold across the populations where it's been tested.

The intervention improves the primary outcome at standard doses in healthy adults.

The intervention improves the primary outcome at standard doses in healthy adults.

Mechanistic and trial evidence converge on a real, replicable effect.

The effect size is large enough to matter clinically, not just statistically.

The headline effect shrinks once you account for trial quality.

The headline effect shrinks once you account for trial quality.

The headline effect shrinks once you account for trial quality.

Confounding and publication bias inflate the apparent benefit.

Confounding and publication bias inflate the apparent benefit.